OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: University of California, Irvine

5 Projects | 5 Researchers | $833,000 Invested

2022

University of California, Irvine

Elizabeth Thomas

Salivary neurofilament light and YKL-40 as prognostic biomarkers of cognitive decline.

  • Funding Amount: $175,000
  • Organization Type: Academic/Nonprofit
  • Program: Diagnostics Accelerator
  • Target: Neuronal Degeneration
  • Status: Closed

2016

University of California, Irvine

Masashi Kitazawa, PhD

A potent lipoxin analogue as a potential treatment for Alzheimer's disease

  • Funding Amount: $328,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Neuroinflammation
  • Status: Closed

2009

University of California, Irvine

Zhiqun Tan, MD, PhD

Efficacy of herbal extract, tetramethylpyrazine, in Alzheimer's transgenic mice

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2005

University of California, Irvine

Steven Schreiber, MD

Efficacy of the Histone Deacetylase Inhibitor, SAHA, in AD Transgenic Mice- A Proof-of-Concept Study

  • Funding Amount: $130,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2002

University of California, Irvine

Carl Cotman, PhD

Phase I Pilot Study of Combination Antioxidants in Aging

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed